Your hands can offer early clues to liver problems. Changes like red palms, itchy skin, brittle nails, and trembling fingers ...

Clinical trials for a laser treatment targeting this common eye disease will begin in Finland next spring, and researchers hope it could become available to patients within three years. About one in ...

Building on earlier studies showing its benefits for type 2 diabetes, a new study has revealed the experimental drug IC7Fc ...

An anti-inflammation injectable drug called dupilumab can reduce mucus buildup and improve breathing among asthma patients, a ...

The world’s deadliest infectious disease urgently requires new and effective antibiotics. Researchers have created a promising new compound that may mark a major step forward in the global effort to ...

If approved, it would be the first major new drug treatment for Parkinson’s in half a century. Richard Mailman, a University ...

Greater baseline disease pruritus and quality of life impairment are associated with higher rates of super response to dupilumab in patients with AD.

Basel, October 29, 2025 – Novartis today presented new ianalumab data in Sjögren’s disease, the second most prevalent rheumatic autoimmune disease 2, at a late-breaker presentation during the American ...

Type 2 diabetes (T2D) is a chronic metabolic disorder characterised by insulin resistance and impaired insulin secretion, ...

Researchers from the University at Albany and NYU Grossman School of Medicine have found a way to block a key cellular ...

Santhera Pharmaceuticals Holding Ag (($SPHDF)) announced an update on their ongoing clinical study. Santhera Pharmaceuticals is conducting a study ...

This story, originally published in September, is being resurfaced following the Texas attorney general’s lawsuit against the makers of Tylenol. President Donald Trump and other federal officials on ...